Could Lab-Grown brain cells ease Parkinson's?

NCT ID NCT05901818

Recruiting now Disease control Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This early-stage trial tests whether implanting specially grown dopamine-producing cells into the brain is safe and can help people with Parkinson's disease. Six participants receive their own lab-grown cells placed into a brain region that controls movement. The study measures changes in movement scores and tracks any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous induced neural stem cell-derived dopaminergic precursor cells
What this could lead to: If successful, this approach could point toward a way to replace lost dopamine cells in the brain, potentially easing Parkinson's motor symptoms.
What could go wrong: This is a very early, small trial with only 6 participants, so results may not apply to everyone. Risks include surgical complications and the possibility that the implanted cells do not work or cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

Xuanwu Hospital Capital Medical University
RECRUITING

Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.